Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02259036 · ClinicalTrials.gov registry record · NA

Using Smartphones to Enhance the Treatment of Childhood Anxiety

A NA study of Anxiety, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT02259036: Completed NA study of Anxiety, sponsored by University of Pittsburgh.

NCT02259036 is a NA study of Anxiety that has completed, run by University of Pittsburgh. The registered enrollment target is 40 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02259036, a NA study of Anxiety, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The primary goal of this research study is to develop an interactive smartphone app that could be used to increase the effectiveness of talk therapy such as cognitive behavioral therapy (CBT) for child anxiety.

Primary Outcome

Anxiety severity will be rated by an IE on the Pediatric Anxiety Rating Scale (PARS) (RUPP Study Group, 2002). A total score was computed by summing six items assessing anxiety severity, frequency, distress, avoidance, and interference during the previous week. Treatment response will be defined as a 35% reduction in PARS from pre- to post-treatment.

Conditions Studied

Interventions

  • OTHER Ecological Momentary Treatment Enhancement

Study Locations (1)

Pennsylvania

  • University of Pittsburgh, Dept. of Psychology - Pittsburgh

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2014-08
Est. Completion 2017-05-31
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT02259036 record still lists

NCT02259036 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Ecological Momentary Treatment Enhancement is the first listed.

NCT02259036 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02259036 about?

NCT02259036 is a clinical study titled "Using Smartphones to Enhance the Treatment of Childhood Anxiety". The primary goal of this research study is to develop an interactive smartphone app that could be used to increase the effectiveness of talk therapy such as cognitive behavioral therapy (CBT) for child anxiety.

What is the current status of trial NCT02259036?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2014-08. Estimated completion is 2017-05-31.

What conditions does trial NCT02259036 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT02259036?

The interventions under investigation include: Ecological Momentary Treatment Enhancement (OTHER).

Who is sponsoring clinical trial NCT02259036?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02259036 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02259036's enrollment target sits among peer trials

40 266th of 364 higher than 83 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02259036, the US trial registry maintained by the National Library of Medicine. NCT02259036 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.